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Abstract.  The abilities of malignant tumor cells to 
bind and migrate through basement membranes are 
important  steps in invasion and metastasis.  Malignant 
tumor cells would therefore be expected to express 
receptors on their surfaces for basement membrane 
and stromal components,  such as collagens, laminin, 
and fibronectin,  although the pattern of expression of 
these receptors on the malignant  cells may be different 
from that on their normal progenitors.  We report here 
that chemically transformed tumorigenic human cells 
express an altered pattern of integrin  receptors on their 
cell surfaces as compared with their untransformed 
nontumorigenic  counterparts.  Specificially, N-methyl- 
N'-nitro-N-nitrosoguanidine  transformation  of HOS 
cells into highly tumorigenic cells results in a 
significant specific increase in the expression of (in 
descending order of level of cell surface expression) 
the integrins  a6/151, o~2/~1, and otl/~/1, which are 
receptors for laminin,  collagens, and collagen type IV 
and laminin,  respectively. The level of expression of 
two fibronectin receptor integrins,  c~5//5'1 and a3//~l, 
are,  however, unaltered,  whereas the level of expres- 
sion of vitronectin receptor integrin,  av//~3, is drasti- 
cally reduced on the transformed cells.  Consistent with 
the increased expression of laminin  and collagen 
receptors and the decreased expression of vitronectin 
receptors on the transformed cells, these cells attached 
three- to fivefold more strongly to laminin  and colla- 
gen but attached very poorly to vitronectin.  The 
MNNG-HOS cells were also found to have a greater 
potential for invasion through  reconstituted basement 
membrane,  matrigel,  the major components of which 
are laminin  and type IV collagen.  The invasion of 
both the HOS and MNNG-HOS cells was inhibited 
45-50%  by a polyclonal anti-fibronectin  receptor anti- 
body. However, although the invasion of HOS cells 
could be inhibited up to 75 % by an anti-or6 monoclo- 
nal antibody, a  similar concentration of this antibody 
had no effect on the ot6-overproducing MNNG-HOS 
cells.  A  fivefold higher concentration of this antibody 
did result in partial  inhibition of MNNG-HOS inva- 
sion.  These data indicate a critical role for the o~6//~1 
laminin  receptor in the invasion of these cells through 
basement membranes and demonstrate that chemical 
transformation  of nontumorigenic human cells to 
highly tumorigenic cells is associated with an altered 
pattern of integrin expression which may play a direct 
role in the increased capacity of these cells to bind 
and invade through basement membranes. 
M 
ALIGNANT transformation  of cells frequently re- 
suits in decreased expression of extracellular  ma- 
trix components such as fibronectin,  laminin,  and 
collagen  (12,  13,  15, 35). In addition,  invasive carcinomas 
consistently  exhibit a defective extracellular  basement mem- 
brane adjacent to the invading tumor cells in the stroma (22). 
Malignant tumor cells also acquire the capability to actively 
invade basement membranes and migrate  through  the sur- 
rounding  stroma.  To form metastases at distant sites, malig- 
nant tumor cells must penetrate the subendothelial  basement 
membrane during  the processes of intra- and extravasation. 
Tumor cell interaction with the extracellular  matrix therefore 
occurs at multiple stages i  n the metastatic  cascade.  It there- 
fore follows that to interact  with basement membranes and 
tissue  stroma,  invading tumor cells must express  adequate 
numbers of receptors for basement membrane and  stromal 
components.  Thus,  although  oncogenic transformation  may 
result  in decreased expression  of extraceUular  matrix  pro- 
teins,  malignant  tumor cells are likely to express  receptors 
for extracellular  matrix  components,  especially for those 
found in basement membranes such as laminin and type IV 
collagen.  In addition,  the pattern  of receptor expression  is 
likely to be different for the invasive and metastatic  cells as 
compared with that on the cells of the tissue of origin. 
©  The Rockefeller University  Press, 0021-9525/90/02/481/9  $2.00 
The Journal of Cell Biology, Volume 110, February  1990 481 ~,89  481 A family of cell surface receptors called integrins,  which 
interact with extracellular matrix proteins, has recently been 
characterized  (3,  14,  27).  Integrins  are  or/3 heterodimeric 
transmembrane proteins.  There are three known/3 subunits 
(/31, 132, and/33),  each of which  is  shared  by different c~ 
subunits which appear to confer ligand  specificity. The 131 
integrin family includes receptors for fibronectin,  laminin, 
and collagen (10, 14, 29) and the/33 family includes recep- 
tors for vitronectin  (14). 
To determine whether malignant transformation of human 
cells results in an altered expression of the integrin fibronec- 
tin,  collagen,  laminin,  and vitronectin  receptors,  we com- 
pared specific integrin  expression on a pair of human cell 
lines,  HOS and MNNG-HOS. HOS is a human osteogenic 
sarcoma call line that is nontumorigenic in nude mice (26). 
MNNG-HOS cell line was derived from HOS cells by treat- 
ment of these cells with N-methyl-N'-l~tro-N-ffntrosoguamdine 
(MNNG) t (26),  a  known potent carcinogen.  The  MNNG- 
HOS cells were found to be highly tumorigenic (26). In addi- 
tion,  DNA from MNNG-HOS calls could transform  NIH- 
3T3 cells, whereas DNA from the HOS cells could not (4), 
suggesting that MNNG caused genetic alterations  in HOS 
ceils that gave rise to a transferable transforming gene. This 
gene has subsequently been shown to be the met oncogene 
(24) encoding a protein with tyrosine kinase activity (6). 
We report here that chemical transformation of HOS cells 
results  in a  significant  specific increase  in ot6/B1 (laminin 
receptor)  (29),  cx2/~  (collagen  receptor)  (10),  and  otl/ffl 
integrins and a decrease in av/B3 (vitronectin receptor) ex- 
pression.  This altered pattern of integrin expression on the 
tumorigenic  transformed  cells,  as  compared  with  the  un- 
transformed cells, endows these cells with an increased abil- 
ity to bind and invade through basement membranes. 
Materials and Methods 
Sodium [t25I]iodide and [32p]dCTP were purchased from Amersham Corp. 
(Arlington  Heights, IL). Chemicals used for SDS-PAGE were from Bio-Rad 
Laboratories (Richmond, CA). Piasmid containing the cDNA encoding the 
B (hP32) subunit of the human fibrone¢tin receptor (2) and rabbit anti-hu- 
man fibronectin and vitronectin receptor antisera were from Drs.  Erkki 
Ruoslnhti and Michael Pierschbecher (La Jolla Cancer Research  Founda- 
tion, La Jolla, CA). The anti-fibroneetin  receptor antibody reacts with both 
the a5 and E1 subunits of the fibronectin receptor (2). The anti-vitronectin 
receptor antibody reacts  with both otv and B3 subunits, of the vitronectin 
• receptor (30), but the preparation used here does have some antibody cross 
reacting with El subunit. Mouse anti-human VLA-I monoclonai antibody 
(TS2/7) was a kind gift from Dr. Martin Hemler (Dana-Farber Cancer Insti- 
tute, Boston, MA), and anti-VLA-2  c~ subunit and anti-VLA-3  ¢x subunit 
(J143) were kind gifts from Dr. Ken Pischel (University of California at San 
Diego, San Diego, CA) and Dr. A. Albino (Memorial Sloan-Kettering Can- 
cer Center, New York), respectively. Monoclonal antibodies against VLA-5 
¢x subuult and the common Bl subunit were kind gifts from Dr.  Carolyn 
Damsky  (University of California at San Fransico,  CA). Monoclonal anti- 
body to VLA-6 ¢x subunit (GOH3) was a kind gift from Dr. A. Sonnenberg 
(Red Cross Blood Transfusions  Services,  Amsterdam, The Netherlands). 
HOS (TE-85, clone F5) and MNNG-HOS (TE-85, clone F5) cell lines were 
1.  Abbreviation  used  in  this  paper:  MNNG,  N-methyl-N'-nitro-N- 
nitrosoguanidine. 
obtained from American Type Culture Collection (Rockville,  MD). Colla- 
gens type I and IV were purchased from Sigma Chemical Co.  (St.  Louis, 
MO). Fibronectin  and vitronectin  were purchased from Telios Pharmaceuti- 
cals (La Jolla, CA). Laminin was a gift from Dr. Max Wicha (University 
of Michigan, Ann Arbor, MI). Hybridoma culture supernatants against ma- 
jor histocompatibility  complex antigen (HLADR)  and the fluorochrome 
R-phycoerythrin,  used as controls in the antibody inhibition  of invasion as- 
says, were obtained from Drs. E "lhkei and P. Lansdorp (Terry Fox Labora- 
tory, Vancouver, British Columbia, Canada). 
Cell Cultures 
HOS, MNNG-HOS,  and MG-63 cells were cultured in DME supplemented 
with 10% heat-denatured FCS, 1% glutamine,  I00 Utml penicillin, and 100 
#g/ml streptomycin  (Gibeo Laboratories Grand Island, NY).  For routine 
subculturing,  cell monolayers  were washed with PBS (150 mM NaCl,  10 
mM sodium phosphate,  pH 7.3) and detached with 1 mM EDTA. Total cell 
numbers were determined by counting on a counter (model  ZBI; Coulter 
Electronics Inc., Hialeah, FL). 
Cell Labeling and lmmunoprecipitations 
Cells were either labeled with [32p]orthophosphate or were surface labeled 
with  n25I. For  32p  labeling, cell  monolayers  were  exposed  to  [32p]or- 
thophosphate (200 ~Ci/ml) in phosphate-free  DME for 18 h. The medium 
was then removed, and cells were harvested and extensively washed in PBS 
containing CaC12 (1 raM) and MgC12 (1 mM) to remove any free 32p. For 
surface  labeling with t25I, cells were harvested and resuspended  in PBS 
containing CaCh (1 raM) and MgCIz (1 mM). Cells were then surface la- 
beled with tzsI as described previously  (8).  Labeled cells were lysed, and 
the integrins immunoprecipitated  with the respective antibodies and protein 
A-Sepharose (Sigma Chemical Co.) as described previously (8, 9). The an- 
tigen-antibody complexes were dissociated by boiling in sample buffer (200 
mM Tris-HCl, pH 6.8, containing 3% SDS,  10%  glycerol,  and 0.001% 
bromophenol blue).  Samples  were analyzed by electmphoresis in 7.5% 
SDS-polyacrylamide gels (21) followed by autoradiography. 
Isolation and Analysis of  mRNAs 
Total cellular RNA was prepared from HOS, MNNG-HOS, and MG-63 cell 
lines by the guanidinium/cesium chloride method (23, 32). The RNAs (10 
#g) were resolved by agarose gel electrophoresis,  transferred to nitrocellu- 
lose filters, and probed with 32p-~]1 integrin cDNA as described previously 
(2, 7). 
Cell Attachment Assays 
Attachment of HOS and MNNG-HOS  cells to protein-coated  microtiter 
wells was carried out as described by Ruoslahti  et al. (28). 
In Vitro Invasion Assay 
The relative abilities of HOS and MNNG-HOS cells to invade through base- 
ment membranes was assayed quantitatively using an in vitro invasion  assay. 
The assay was modified from that described by Albini et al. (1). Basement 
membrane matrigel (Collaborative  Research, Bedford, MA) which consists 
of laminin, type IV collagen,  beparan sulfate proteoglyean,  and entactin 
(nidogen)  (20) was used as a barrier for the invading ceils.  The details of 
the assay will be published elsewhere (Saulnier, R., and S. Dedhar, manu- 
script in preparation). Briefly, Transwclls (Costar, Cambridge, MA) which 
consist of upper and lower compartments separated by polycarbonate filters, 
were used in the assay. The 13-mm-diameter  filters were coated with type 
I collagen to facilitate the attachment of the invaded cells. These filters were 
overlayed with polyvinylpyrolidone-free  polyearbonat¢  filters (12 ~m pore 
size; Nucleopore,  CA), which were coated with a 1:3 dilution of matrigel. 
The optimum concentration of matrigel  used was determined empirically. 
Cells  were  labeled  in  standard  tissue  culture  medium  for  24  h.  with 
[3Hltbymidine (1 eCi; 20 Ci/mmol), tested for viability by trypan blue ex- 
clusion, washed extensively to remove unincorporated label, resuspended 
Figure 1.  Morphology of HOS and MNNG-HOS cells. The photomicrographs represent the morphology of cells growing under standard 
tissue culture conditions:  i.e.,  DME  in  10%  FBS.  (A) HOS  cells;  (B) MNNG-HOS  cells.  Bar,  25  #m. 
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(10  s cells/well). An aliquot of the radiolabeled cells was used to determine 
the initial radioactivity applied. 
Invasion  of  the cells through the matrigel  was allowed  to proceed for 18 h 
at 37°C. The top, matrigel-containing filter was then removed, and the 
amount of radioactivity associated with the bottom, collagen-coated filter 
was determined by liquid scintillation counting. Invasion of the cells was 
confirmed by fixing and staining the cells on the bottom filter with 3.7% 
paraformaldehyde, 0.5 % toluidene blue and visualizing the cells under an 
inverted microscope. The percent invasion was quantitated by dividing the 
number of 3H counts per minute on the bottom filter by the initial 3H 
counts per minute applied. Each experiment was carried out in quadru- 
plicate. 
For antibody inhibition assays, the cells were preincubated with the re- 
agents in I00 t~l of  DME containing 0.1% BSA for 30 min at 4°C. Antibodies 
were also present in the upper chamber during the invasion  assay and were 
also incorporated into the matrigel in similar concentrations. 
Results 
To  determine  whether  chemical  transformation  of human 
cells  into tumorigenic  and  invasive cells resulted  in altera- 
tions in the integrins,  we analyzed integrin phosphorylation 
and the pattern of specific integrin expression at the cell sur- 
face of HOS and MNNG-transformed HOS cells, the differ- 
ences in cell morphology of which are shown in Fig.  1. The 
Figure 2.  Immunoprecipitation of integrins  from 32p-labeled and 
~25I-surface labeled HOS and MNNG-HOS cells.  Cells were ra- 
dioactively labeled, extracted, and immunoprecipitated with a rab- 
bit  anti-human  fibronectin  receptor  antiserum  as  described  in 
Materials  and  Methods.  Immunoprecipitates  were  analyzed  by 
SDS-PAGE  under  nonreducing  conditions,  and  the  bands  were 
visualized by autoradiography.  (A, lanes 1 and 3)  ~25I-surface la- 
beled  cells;  (lanes  2  and  4)  [32p]orthophosphate-labeled  cells. 
Lanes 1 and 2 are HOS cells, and lanes 3 and 4 are MNNG-HOS 
cells.  (B) SDS-PAGE of nonimmunoprecipitated 32p-labeled HOS 
(lane 1 ) and MNNG-HOS (lane 2) lysates.  Molecular weight mark- 
ers are myosin heavy chain (200K), ~-galactosidase (116K), phos- 
phorylase fl (94K),  and albumin (67K). 
reason for determining the status of integrin phosphorylation 
upon chemical  transformation  was twofold.  First,  the pro- 
tooncogene, met, which is activated upon MNNG transfor- 
mation  of HOS  cells  encodes  tyrosine  kinase  activity  (6), 
and,  second,  Rous sarcoma virus transformation of chicken 
cells has been shown to result in the phosphorylation of both 
the ¢  and fll chicken integrin homologues (11).  The conse- 
quence,  if any,  of this  phosphorylation  on  cell  adhesion, 
however, has yet to be determined. 
As shown in Fig. 2, we were unable to demonstrate phos- 
phorylation of integrins  in either of the cell  lines,  HOS or 
MNNG-HOS. In this experiment, cells from parent cultures 
were  subcultured;  one  half  were  labeled  with  [32p]or- 
thophosphate,  and the other half were surface labeled with 
~I.  Integrins  could  be  clearly  immunoprecipitated  from 
~25I-labeled  cells  but  not  from 32p-labeled cells  (Fig.  2  A), 
demonstrating that, although fll integrins are present on both 
cell lines,  they are not phosphorylated.  As shown in Fig.  2 
B,  many  other  membrane-associated  proteins  were  32p la- 
beled by this procedure, and therefore the lack of demonstra- 
tion of 32p labeling  of integrins  was not due  to incomplete 
labeling. It would therefore appear that MNNG-induced ac- 
tivation of a  tyrosine kinase-encoding  protooncogene  does 
not result  in the phosphorylation  of fll  integrins. 
The  immunoprecipitation  of ~25I-labeled  cells  with  anti- 
fibronectin  receptor  antibody,  which  contains  antibodies 
against the fll and o~5 integrin subunits (2), suggested that the 
MNNG-HOS cells may express an altered pattern of integrin 
expression as compared with  HOS cells (Fig.  2  A,  lanes  1 
and  3).  To  analyze  the  patterns  of integrin  expression  on 
these two cell lines  in more detail,  we immunoprecipitated 
each of the integrin heterodimers from both cell lines using 
subunit-specific  monoclonal  antibodies. 
The results  are  shown  in  Fig.  3.  Equivalent  numbers  of 
HOS and MNNG-HOS cells (•70%  confluent) were labeled 
with  ~25I and  lysed,  and  equivalent  ~25I radioactive  counts 
were  immunoprecipitated  with  the  antibodies  described  in 
Fig. 3. Immunoprecipitation with an anti-ill monoclonal an- 
tibody  (Fig.  3,  lanes  1  and 2)  demonstrates  that increased 
numbers of fll integrins are expressed on MNNG-HOS cells 
as compared with HOS cells.  More specifically, the hetero- 
geneous ot band, which includes ot subunits 2-6 because they 
all have very similar molecular weights (10), is more diffuse 
in the MNNG-HOS cells than in the HOS cells. Immunopre- 
cipitation  with  a  subunit-specific  monoclonal  antibodies 
demonstrated  that there  is no difference  in the amounts  of 
c~ 3/ill (Fig. 3, lanes 3 and 4) and c¢5/fll  (lanes 5 and 6) inte- 
grin  expressed  on  these  two  cell  lines,  ot3/~l  integrin  has 
been shown to be a low affinity receptor for fibronectin, lami- 
nin,  and  collagen  (10,  25,  33),  whereas  c¢5/fll  is a  higher 
affinity receptor specific for fibronectin (10,  31).  The c~5/fll 
integrin  is expressed  at much  lower  amounts  on  both  cell 
lines than  is the a3/fll  integrin. 
Immunoprecipitation with anti-c~6 and anti-a2 monoclo- 
nal  antibodies,  however,  provided  what  appears  to  be  the 
most  significant  difference  in  integrin  expression  on  these 
two cell lines. As shown in Fig. 3, there is very little expres- 
sion of c~6/fll  on HOS cells, but a >10-fold increased expres- 
sion of this  integrin  on MNNG-HOS  cells  (Fig.  3,  lanes  7 
and 8). In fact, or6 is the most abundant ot subunit expressed 
on MNNG-HOS cells, c~6/fll  has been shown to be a specific 
receptor  for  laminin  (29).  Similarly,  the  integrin  c~2/fll, 
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and immunoprecipitated with the appropriate antibodies as described in Materials and Methods. Immunoprecipitates were analyzed by 
SDS-PAGE under nonreducing conditions, and the bands were visualized by autoradiography. Lanes 1, 3, 5, 7, 9, and//are HOS cells, 
and lanes 2, 4, 6, 8, 10, and 12 are MNNG-HOS cells. (Lanes I and 2) Anti-human/31 monoclonal antibody; (lanes 3 and 4) anti-human 
or3 monoclonal antibody; (lanes 5 and 6) anti-human  or5 monoclonal antibody; (lanes 7 and 8) anti-human  ct6 monoclonal antibody; 
(lanes 9 and 10) anti-human cd monoclonal antibody; (lanes//and 12) anti-human c~2 monoclonal antibody. Molecular weight standards 
are similar to those described in Fig. 2. 
which is a collagen receptor (10), is expressed at an approxi- 
mately fivefold higher level on MNNG-HOS cells than on 
HOS cells (Fig. 3, lanes//and  12).  A  twofold increase in 
the expression of  od//31 in MNNG-HOS cells is also apparent 
when immunoprecipitation is carried out with an t~l subunit- 
specific monoclonal antibody (Fig. 3, lanes 9 and 10). The 
identity of the ligand for integrin cd//31 remains unclear, al- 
though it may be a human homologue of a laminin-binding 
rat heterodimer with similar relative molecular masses (16). 
The human cd/~ integrin may also be a receptor for collagen 
(18). 
Another interesting feature of the/31  integrins expressed 
by MNNG-HOS  cells is  that the common/31  subunit ex- 
pressed by these cells has a slightly higher apparent relative 
molecular mass than the B1 subunit expressed on HOS cells 
(Fig. 3, lanes 1-12).  The difference in the relative molecular 
mass may be due to the expression of a different mRNA or to 
differences in posttranslational modifications such as phos- 
phorylation or glycosylation. The difference is unlikely to be 
due to phosphorylation since the/31 integrins are not phos- 
phorylated in either cell line (Fig. 2). We therefore carried 
out Northern blot analysis of total RNA from the two cell 
lines to determine whether the MNNG-HOS cells express an 
altered/31 mRNA. As shown in Fig. 4 the size and the inten- 
sity of the mRNA from both cell lines is identical and is simi- 
lar to that expressed in another osteosarcoma cell line, MG- 
63. The altered size of the/31  subunit is therefore unlikely to 
be due to the expression of a larger mRNA and is likely to 
be due to increased glycosylation. In addition, whereas im- 
munoprecipitation with anti-/31 antibody demonstrated more 
/31 expressed on the MNNG-HOS cell surfaces,/31 mRNA 
levels appear to be the same in both cell types. This suggests 
that MNNG transformation may have resulted in posttransla- 
tional modification of/31 processing and transport, leading 
to increased/31 expression on the cell surface. 
We  also  determined  the  expression  of  the  vitronectin 
receptor, an integrin belonging to the/33 integrin family (14, 
27), on the two cell lines. Immunoprecipitation of ~25I-sur- 
face labeled cells with a rabbit anti-human vitronectin recep- 
tor antiserum (30) demonstrated that the MNNG-HOS cells 
express greatly reduced levels of this receptor as compared 
with the HOS cells (Fig. 5). In particular, the/33 subunit is 
present in much lower amounts on the surface of MNNG- 
HOS cells. 
To determine the biological consequences of these changes 
in integrin expression, attachment of HOS and MNNG-HOS 
cells was carried out on various ligands. As can be seen from 
Fig.  6,  both cell  lines  attach  well  to  fibronectin, but  the 
MNNG-HOS cells demonstrated stronger attachment to col- 
lagen type I and much stronger attachment to the basement 
membrane components collagen type IV and laminin, cor- 
relating well with the increased expression of the receptors 
for these two ligands on these cells. In addition, consistent 
with  the  demonstrated  expression  of reduced  vitronectin 
receptors on MNNG-HOS cells,  these cells attached very 
poorly to vitronectin as compared with the untransformed 
HOS cells (Fig.  6). 
To determine whether there were any differences in the 
ability of HOS and MNNG-HOS cells to invade a  recon- 
stituted basement membrane,  invasiveness of the two cell 
lines was quantitatively determined with the use of  an in vitro 
invasion assay through basement membrane matrigel. Matri- 
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HOS  cells.  Cytoplasmic  RNA  was  extracted  as  described  in 
Materials and Methods. The RNA (10 #g/lane) was resolved by 
electrophoresis  on  0.8% agarose  gel  containing formaldehyde 
(6%), transferred onto a nitrocellulose filter, and probed with 32p_ 
labeled fibronectin receptor/3 subunit (/31) cDNA (2). (Lanes 1-3) 
MNNG-HOS, HOS, and MG-63, respectively. 
gel has been shown to consist of laminin, type IV collagen, 
heparan sulfate proteoglycan, and entactin (nidogen) (20). 
As  shown in Table I,  the MNNG-HOS cells were signifi- 
cantly (p <  0.05)  and uniformly more invasive than HOS 
Figure  5.  Immunoprecipitation of the 
vitronectin receptor (c~v//33) from ~25I- 
surface labeled HOS and MNNG-HOS 
cells. Cells were labeled, extracted, and 
immunoprecipitated with a rabbit anti- 
human vitronectin receptor antiserum as 
described in Materials and Methods. The 
immunoprecipitates were  analyzed  by 
SDS-PAGE under  nonreducing condi- 
tions, and the bands were visualized by 
autoradiography. (Lane  1)  HOS cells; 
(lane 2) MNNG-HOS cells. Molecular 
weight markers are similar to those de- 
scribed in Fig. 2. 
cells in five different  experiments. Although thopercent inva- 
sion fluctuated from one experiment to another, the MNNG- 
HOS cells were more invasive relative to the HOS cells in 
all five experiments. The invasive potential of the two cell 
lines were compared relative to the invasiveness of a human 
lung fibroblast cell line (IMR-90), the invasive potential of 
which was found to be negligible (Table I). 
The invasion of both HOS as well as MNNG-HOS cells 
was  inhibited  by  an  anti-fibronectin receptor antiserum, 
which contains antibodies against both c¢5 and/31  subunits 
(2), when these cells were preincubatext with this antiserum 
and when this antibody was incorporated in the matrigel (Ta- 
ble II).  Invasion of the HOS cells was also profoundly in- 
hibited by the anti-or6 monoclonai antibody (GOH3) (29) 
under similar conditions (Table II). However, the invasion of 
the ot6-overproducing MNNG-HOS cells was not inhibited 
by similar concentrations of this antibody. The inability of 
the invasion of MNNG-HOS  cells to be inhibited by the 
anti-c~6 antibody is most likely due to the much higher level 
of expression of or6 on these cells. The use of fivefold higher 
concentrations of antibody did result in partial inhibition of 
MNNG-HOS cell invasion (Table ID. These data thus indi- 
cate that the integrin ot6//31 plays an important role in the in- 
vasion by these cells through basement membranes. The in- 
creased invasion of the MNNG-HOS cells may thus at least 
partially be due to the very high level of expression of the 
ot6//31 integrin on these cells. The partial inhibitory effect of 
the anti-fibronectin receptor antiserum on invasion may be 
due to the inhibition of the common/31 function rather than 
a specific effect of this antiserum on ot5//31 (fibronectin re- 
ceptor). Similar experiments with adhesion-perturbing anti- 
bodies to ~2 (unavailable at the present time) should reveal 
whether this integrin is also involved in the basement mem- 
brane invasion by these cell lines. 
Discussion 
The behavior of malignant tumor cells is quite different from 
that of their parental normal counterparts. Apart from their 
ability to proliferate in an uncontrolled manner at the pri- 
mary site,  some of the malignant tumor cells also acquire 
phenotypes which make them less adhesive to the surround- 
ing stroma at the primary site but at the same time are able 
to attach and migrate through basement membranes.  It is 
therefore highly likely that such cells would express on their 
cell surfaces receptors (integrins) for various components of 
the basement membrane such as laminln and type IV colla- 
gen, In addition, it is likely that the pattern of integrin ex- 
pression on the malignant cells would be different from that 
on the parentad  untransformed cells,  reflecting the altered 
phenotype of these cells. 
To determine whether transformation of human cells into 
malignant cells results in an altered pattern of integrin ex- 
pression, we analyzed specific integrin expression on the cell 
surfaces of HOS and MNNG-HOS cells (26). Unlike rodent 
cells,  malignant  transformation  of  human  cells  is  very 
difficult. The availability of chemically transformed malig- 
nant cells (MNNG-HOS) and their parental nontumorigenic 
counterparts (HOS cells) provides a suitable model system 
for comparative studies of tumorigenic vs. nontumorigenic 
human cells. 
Analysis of integrin expression on these two cell lines has 
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Figure 6.  Attachment of HOS  and MNNG-HOS 
cells to collagen type IV, laminin,  collagen type I, 
fibronectin,  and  vitronectin.  Attachment  assays 
were carried out on ligand-coated  microtiter wells 
as described  by Ruoslahti et al.  (28).  Cells  (3  x 
104) were plated  in wells  coated  with  increasing 
concentrations  of the indicated ligand in the pres- 
ence of 2.5 mg/ml BSA. The plates were incubated 
at room temperature for 3 h in an atmosphere  of 
7%  CO2. Nonattached  cells  were  washed  away 
with  PBS,  and the attached cells were fixed with 
3 % paraformaldehyde and stained with 0.5 % tolui- 
dene blue in 3.7% paraformaldehyde. Cell attach- 
ment was measured as a function of absorbance of 
destained  cells at 495  nM. 
Table L In Vitro Invasion of  HOS, MNNG-HOS, 
and IMR-90 Cells through Reconstituted Basement 
Membrane Matrigel 
Cells invaded 
Experiment  HOS  MNNG-HOS  IMR-90 
%  %  % 
1  1.71  4.65  0.70 
2  1.81  2.41  0.82 
3  4.97  8.90  0.59 
4  2.40  3.70  -- 
5  1.96  5.74  - 
The increased invasiveness of MNNG-HOS  cells was statistically significant 
(p < 0.05) as determined by the Mann-Whitney test. The invasion assay was 
carried out and quantitated  as described in  Materials and Methods. 
revealed,  first,  that/~1  and/~3  integrin heterodimers are not 
phosphorylated on either cell line despite the activation of a 
tyrosine  kinase-encoding  oncogene  (met)  in  the  MNNG- 
HOS  cells.  Second,  when  individual  integrin  heterodimer 
expression  was  analyzed,  it  was  found  that  the  MNNG- 
treated cells expressed similar levels of fibronectin receptor 
structures, cx3//31 and ~5//~1, but expressed greatly increased 
levels  of laminin  and collagen  receptors,  namely  integrins 
cx6//~l,  ot2//~l, and oll//31 (Table HI). Third, the common/~1 
subunit of all of these receptor structures  appears to have a 
slightly higher relative molecular mass in the MNNG-HOS 
cells than the/~1 subunit in HOS cells. This difference in mo- 
lecular mass is not due to the expression of a different size 
mRNA but rather appears  to be due to altered  posttransla- 
tional modification.  Since this alteration is not due to phos- 
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MNNG-HOS Cells by Anti-integrin Antibodies 
Cells  Cells invaded*  Inhibition 
HOS 
Control 
Anti-fibronectin 
receptor antiserum 
(1:50) 
Anti-odi antibody 
(1:2) 
%  % 
5.0  -I-  1.2 
2.7 -t- 0.8  46 
1.5 + 0.4  70 
MNNG-HOS 
Control  8.1  +  1.5 
Anti-fibronectin 
receptor antiserum 
(1:50)  5.2 +  1.1 
Anti-o6 antibody 
(1:2)  8.3  +  1.7 
Anti-or6 antibody 
(fivefold more 
concentrated)  4.8  +  1.2 
36 
41 
The effect of anti-fibronectia receptor antiserum was controlled for by carrying 
out replicate assays in the presence of equivalent dilutions of normal rabbit se- 
rum, which did not effect the invasion of either cell line. The effect of anti-a6 
hybridoma  culture supernatant was controlled for by carrying out replicate  as- 
says in the presence of equivalent dilutions of hybridoma culture  supernatants 
containing antibodies against human major histocompatibility complex antigen 
(HLADR) or the flnorochrome R-phycoerythrin, neither of which had a sig- 
nificant  effect  on the invasion of either cell line. 
*Values represent the mean +  SD of thrce separate experiments. Each experi- 
ment was carried out in quadruplicate. Percent invasion was determined as 
described in Materials and Methods. 
phorylation, it is likely to be due to altered glycosylation, al- 
though we do not have any evidence for this as yet. Last, the 
expression of av/33 integrin, which mediates attachment of 
cells to vitronectin, is greatly reduced in the MNNG-trans- 
formed cells. Since we do not at the present time have cDNA 
probes available for the a6, a2, and ~tl subunits, we are un- 
able to correlate the levels of expression of these subunits at 
the cell surface with their mRNA levels. It is therefore con- 
ceivable that the alterations in the levels of cell surface ex- 
pression of these subunits occur at a posttranslational level 
in the processing and transport of these proteins or even be 
due to alterations resulting in increased surface exposure. 
The functional consequence of this difference in the pat- 
tern of integrin expression on these cells is manifested in a 
Table III. Summary of  Alterations in Integrin Subunits upon 
Chemical Transformation of  Human Cells with MNNG 
Integrin 
subunit  Change  Ligands 
/31  Increased/altered  - 
relative molecular mass 
a3  Unchanged  FN/LM/COLL 
or5  Unchanged  FN 
a6  Greatly increased  LM 
a2  Increased  COLL 
al  Increased  LM/COLL IV 
c~v  Decreased  VN 
/~3  Greatly decreased  - 
FN, fibronectin;  LM, laminin; COLL, collagen;  VN, vitronectin. 
much stronger binding of MNNG-transformed cells to lami- 
nin and type IV collagen, both of which are components of 
basement membranes. In addition, the MNNG-transformed 
HOS cells were found to be significantly more invasive than 
the untransformed HOS cells, as determined by the ability 
of these two cell lines to invade through a reconstituted base- 
ment membrane matrigel, the major components of which 
are laminin and type IV collagen. Since the invasion assay 
used  here  determines  all  three  parameters  of  invasion 
through a basement membrane-i.e., attachment to the ma- 
trix, degradation of the matrix, and migration through the 
matrix  (22)-it  is  likely  that  the  increased  expression of 
laminin and collagen receptor integrins on the transformed 
cells may serve to facilitate the first and third parameters of 
basement membrane invasion.  This conclusion is partially 
supported by the ability of anti-or6 antibodies in inhibiting 
the invasion of HOS cells and, at much higher concentrations 
of antibody, of MNNG-HOS cells through matrigel. The re- 
quirement of much higher concentrations of anti-a6 anti- 
body for the invasion of the ot6-overexpressing MNNG-HOS 
cells suggests an important role for this integrin in basement 
membrane invasion by these cells. 
Interestingly,  a  nonintegrin  68,000-Mr  laminin-binding 
protein, expressed on normal epithelial, skeletal muscle, and 
neuronal cells, is also increased on highly metastatic tumor 
cells (22, 34), and tumor-promoting phorbol esters also en- 
hance attachment of NIH-3T3 cells to laminin and type IV 
collagen (17).  Integrin-related complexes mediating attach- 
ment to laminin,  collagen, and fibronectin have also been 
shown to be expressed on metastatic B16  melanoma cells 
(19). Furthermore, poorly differentiated human colon carci- 
noma  cell  lines  have  been  recently  shown  to  attach  and 
spread more strongly on laminin and matrigel than moder- 
ately differentiated cell lines which attach poorly to these 
substrates (5). 
Our results differ from those described recently by Plan- 
tefaber and Hynes (25) in that MNNG transformation of hu- 
man cells does not result in a decrease in the expression of 
c~5/B1 (fibronectin receptor) integrin, as is the case in virally 
transformed rodent cells (25). However, the level of expres- 
sion of ~5/31 is quite low relative to o~3/31 in both the HOS 
and MNNG-HOS cells,  and, because of greatly increased 
laminin and collagen receptors on the MNNG-HOS cells, 
the effective ratio of fibronectin receptors to laminin recep- 
tors or to collagen receptors is greatly decreased on these 
cells. Since Plantefaber and Hynes (25) did not determine the 
level of expression of t~6 and od  subunits  on their trans- 
formed cell lines, it is not clear whether oncogenic transfor- 
mation is generally associated with increased laminin recep- 
tor expression. 
Taken together,  the  results  presented here indicate that 
MNNG transformation of HOS cells results in an altered pat- 
tern  of cell  surface  integrin  expression.  The  greatly  in- 
creased expression of laminin and collagen IV receptors on 
these cells likely endow these cells with an increased capa- 
bility of interacting with basement membranes during inva- 
sion. In addition,  decreased expression of vitronectin receptors 
and low levels of high affinity fibronectin receptor expression 
would render these cells less adhesive to stromal components 
immediately surrounding them. 
Similar studies with other chemically and virally trans- 
formed human cells should provide interesting and important 
The Journal of Cell Biology, Volume 110,  1990  488 data about the role of integrins in the expression of the malig- 
nant phenotype. 
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